4 Healthcare Stock Stories Prescribed for Investors

Teva Pharmaceutical Industries (NYSE:TEVA): Closing price $38.77

Teva, the maker of the market-leading multiple sclerosis drug Copaxone, has filed a petition with the FDA through which it hopes to delay entry into the market of a rival drug, BG-12, developed by Biogen IDEC (NASDAQ:BIIB). The petition requests that the agency not okay  any new multiple sclerosis drug until its safety has been studied by a panel of outside advisors and also revealed that it has found “troubling information” on a publicly accessible website regarding the safety of Biogen’s drug.